- Home
- About
- Find staff
- Maria Ekholm
Maria Ekholm
Researcher
Department of Laboratory-
Average duration of prior treatment lines predicts clinical benefit to eribulin chemotherapy in patients with metastatic breast
cancer
Faye Coe, Vivek Misra, Yamini McCabe, Helen Adderley, Laura Woodhouse, Zaheen Ayub, Xin Wang, Sacha Howell, Maria Ekholm
Breast Cancer Research and Treatment - 2022 -
Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task
Force
E. Razis, M. J. Escudero, C. Palmieri, V. Mueller, R. Bartsch, G. Rossi, S. P. Gampenrieder, H. C. Kolberg, N. Zdenkowski, M. Pavic, R. M. Connolly, L. Rosset, J. Arcuri, H. Tesch, C. Vallejos, J. Retamales, A. Musolino, L. Del Mastro, C. Christodoulou, S. Aebi, S. Paluch-Shimon, S. Gupta, S. Ohno, I. Macpherson, Maria Ekholm, K. Zaman, M. Vidal, C. Chakiba, D. Fumagalli, A. Thulin, I. Witzel, N. Kotecki, M. Gil-Gil, B. Linderholm
ESMO Open - 2022 -
PAM50 subtyping and ROR score add long-term prognostic information in premenopausal breast cancer
patients
C. Lundgren, P. O. Bendahl, S. E. Church, Maria Ekholm, M. Ferno, C. Forsare, U. Kruger, B. Nordenskjold, O. Stal, L. Ryden
Npj Breast Cancer - 2022 -
Real World Evaluation of the Prosigna/PAM50 Test in a Node-Negative Postmenopausal Swedish Population: A Multicenter
Study
U. Kjallquist, B. Acs, S. Margolin, E. Karlsson, L. E. Kessler, S. G. Hernandez, Maria Ekholm, C. Lundgren, E. Olsson, H. Lindman, T. Foukakis, A. Matikas, J. Hartman
Cancers - 2022